510(k) · Cleared
ClearedCrossfix II Memiscal Repair Device
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cayenne Medical, Inc. · GAT Suture, Nonabsorbable, Synthetic, Polyethylene
Cleared on Jun 4, 2012 after a 24-day review. The FDA summary names no predicate by number. 3 later devices descend from it.
- Decided
- Jun 4, 2012
- Review
- 24 days
- Class
- Class II
- Product code
- GAT
- Recalls
- None
- Predicates
- 0
3 later devices descend from it, 1 citing it directly.
- This deviceK121413 Crossfix II Memiscal Repair DeviceCayenne Medical, Inc. · 2012
- Descendant · cites it directly · 2 of its ownK143356 NovoStitch Plus Meniscal Repair SystemCeterix Orthopaedics, Inc. · 2015
- Descendant · 2 generations on · 1 of its ownK180531 NovoStitch Pro Meniscal Repair SystemCeterix Orthopaedics, Inc. · 2018
- Descendant · 3 generations on · 0 of its ownK181772 NovoStitch Pro Meniscal Repair System, CTX-A004 (size 0)Ceterix Orthopaedics, Inc. · 2018
Most influential descendants
Showing 3 of 3 · See all- K143356NovoStitch Plus Meniscal Repair SystemCeterix Orthopaedics, Inc. · 2015 · cites it directly2descendants
- K180531NovoStitch Pro Meniscal Repair SystemCeterix Orthopaedics, Inc. · 2018 · 2 generations on1descendant
- K181772NovoStitch Pro Meniscal Repair System, CTX-A004 (size 0)Ceterix Orthopaedics, Inc. · 2018 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K121413 | Crossfix II Memiscal Repair Device | Cayenne Medical, Inc. | 2012 | — |
| +1 | K143356 | NovoStitch Plus Meniscal Repair System | Ceterix Orthopaedics, Inc. | 2015 | — |
| +2 | K180531 | NovoStitch Pro Meniscal Repair System | Ceterix Orthopaedics, Inc. | 2018 | — |
| +3 | K181772 | NovoStitch Pro Meniscal Repair System, CTX-A004 (size 0) | Ceterix Orthopaedics, Inc. | 2018 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
| 2018 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GAT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GAT device
- #1 K230311 HyperSuturescore 20.2 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
The FDA summary names no predicate by number.
What descends from it? (3)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K143356 | NovoStitch Plus Meniscal Repair System | 2015 | 2 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K143356 (Ceterix Orthopaedics, Inc., 2015) has gone furthest, with 2 descendants of its own.
How does its category compare?
All GAT devicesGAT Suture, Nonabsorbable, Synthetic, Polyethylene: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · GAT
5in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GAT
30in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GAT
1in 2011
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GAT
2,956in 2025
MAUDE reports naming product code GAT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 40 | 1 | 15 |
| 2008 | 4 | 93 | 0 | 15 |
| 2009 | 9 | 57 | 0 | 55 |
| 2010 | 11 | 27 | 3 | 79 |
| 2011 | 1 | — | 1 | 97 |
| 2012 | 6 | 61 | 0 | 253 |
| 2013 | 4 | 123 | 0 | 210 |
| 2014 | 4 | 45 | 0 | 165 |
| 2015 | 7 | 125 | 0 | 626 |
| 2016 | 10 | 139 | 0 | 688 |
| 2017 | 6 | 57 | 0 | 1,104 |
| 2018 | 6 | 95 | 0 | 1,453 |
| 2019 | 4 | 79 | 0 | 1,251 |
| 2020 | 5 | 201 | 0 | 1,220 |
| 2021 | 4 | 92 | 0 | 1,643 |
| 2022 | 5 | 109 | 0 | 1,419 |
| 2023 | 8 | 220 | 0 | 2,038 |
| 2024 | 3 | 140 | 0 | 2,597 |
| 2025 | 5 | 30 | 0 | 2,956 |
| 2026 | 5 | 83 | 0 | — |
What is it indicated for?
The CrossFix® 11 Meniscal Repair Device is intended for approximation of soft tissue in meniscal repair procedures.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K121413 · printed Nov 6, 2026
Cite this page
510(k) Report. “K121413: Crossfix II Memiscal Repair Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121413
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026